Immunology and Microbiology
Lung Cancer Cell Line
100%
Western Blot
75%
Cytotoxicity
75%
Programmed Cell Death
75%
Cell Line
50%
Caspase
50%
In Vitro
50%
Xenograft
25%
Cancer Cell
25%
Monoclonal Antibody
25%
IC50
25%
Tumor Cell Inoculation
25%
Medicine and Dentistry
Small Cell Lung Cancer
100%
Treatment of Small Cell Lung Cancer
100%
Cisplatin
100%
Programmed Cell Death
23%
Lung Cancer Cell Line
23%
Cytotoxicity
23%
Immunoblotting
23%
In Vitro
15%
Lipocortin 5
15%
Cell Line
15%
Treatment Group
15%
Neoplasm
7%
Cancer Cell
7%
Clinical Trial
7%
Xenograft
7%
Tetrazolium
7%
XTT Assay
7%
Tumor Cell Inoculation
7%
Procaspase 8
7%
Monoclonal Antibody
7%
IC50
7%
Caspase
7%
Fluorescein Isothiocyanate
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Small Cell Lung Cancer
100%
Western Blot
20%
Cytotoxicity
20%
Lipocortin 5
13%
Neoplasm
13%
Treatment Group
13%
Chemotherapy
6%
Clinical Trial
6%
Fluorescein Isothiocyanate
6%
Tetrazolium
6%
Procaspase 8
6%
Monoclonal Antibody
6%
Caspase
6%
IC50
6%
Neuroscience
Cisplatin
100%
Cell Line
45%
Cytotoxicity
27%
Immunoblotting
27%
Programmed Cell Death
27%
In Vivo
18%
In Vitro
18%
Lipocortin 5
18%
Monoclonal Antibody
9%
Staining Technique
9%
Caspase
9%
Procaspase 8
9%
Nursing and Health Professions
Small Cell Lung Cancer
100%
Cisplatin
100%
Immunoblotting
20%
Lipocortin 5
13%
Treatment Group
13%
IC50
6%
Xenograft
6%
Tumor Cell Inoculation
6%
Procaspase 8
6%
Tetrazolium
6%
XTT Assay
6%
Tumor Doubling Time
6%
Monoclonal Antibody
6%
Caspase
6%